Fears of Medicare-for-all are weighing on health care ETFs. Is this an opportunity?
How you should trade biotech ETFs.
Health care, internet and oil products have performed well this year.
Losses were as high as 89%.
The segment is delivering some impressive gains after a bout of investor doubt.
Issuers take different approaches to industry and sector exposure.
December was a mostly positive month for sector ETFs.
As biotech companies make the news, investors are left with choices when it comes to ETFs.
Direxion completes splits on 10 ETFs, closures of three.